Overview
A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer
Status:
Completed
Completed
Trial end date:
2012-02-01
2012-02-01
Target enrollment:
Participant gender: